ADVENT LIFE SCIENCES LLP
ADVENT LIFE SCIENCES LLP is a Seed and Series A fund in the US, GB and Europe investing in healthcare-tech.
- Stages
- Seed, Series A
- Sectors
- healthcare-tech
- Invests in
- US-wide, GB, Europe
- Founded
- 2005
- Website
- adventls.com
Check size not disclosed
Thesis
Advent Life Sciences focuses on early- and mid-stage life sciences companies in the UK, Europe, and the US, seeking companies with a "first- or best-in-class approach". Their investments span new drug discovery (small molecules, biologics, and new modalities), med tech, enabling technologies, and vaccines. They invest from Seed stage or Series A onward, backing high-impact, high-potential innovations that can deliver important new medicines for unmet medical needs. Advent Life Sciences has raised multiple funds, including Advent Life Sciences Fund I ($158M), Fund II ($364M), Fund III ($215M), and the Advent-Harrington Impact Fund ($215M).
Common questions
Does ADVENT LIFE SCIENCES LLP invest at the Seed stage?
Yes. ADVENT LIFE SCIENCES LLP lists Seed and Series A among the stages it invests in.
Where does ADVENT LIFE SCIENCES LLP invest?
ADVENT LIFE SCIENCES LLP invests in the US, GB and Europe.